Homevideos Newshealthcare News

    US FDA releases warning letter details for Aurobindo’s New Jersey unit

    videos | IST

    US FDA releases warning letter details for Aurobindo’s New Jersey unit

    Mini

    Aurobindo Pharma stock is under pressure, after the USFDA released details of the warning letter for the company’s New Jersey unit.

    Aurobindo Pharma stock is under pressure, after the USFDA released details of the warning letter for the company’s New Jersey unit.
    The warning letter was issued last month and now the USFDA has released the details of that warning letter. The USFDA says that methods, facilities, manufacturing, processing do not conform to current good manufacturing practice (CGMP).
    It summarises significant violations of good manufacturing practice and they strongly recommend engaging a consultant.
    To know more, watch this video.
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    next story

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng